Is HTA going to save health care budgets or are its premises inherently flawed?
This article was originally published in Clinica
Does the very nature of health technology assessment point the finger of blame for soaring medical costs at the healthcare industry? Is it time to challenge the scope of HTA and call for comparative studies of all healthcare interventions so that the real value of medical technology is more accurately understood in the overall healthcare framework? These are questions on the mind of Miro Palat, president of CzechMed, the Czech medical device industry association